Christopher A Hobson

US Patent:

20150272906, Oct 1, 2015

Filed:

Mar 30, 2015

Appl. No.:

14/673787

Inventors:

Michael K. Jordan - North Smithfield RI, US
Christopher A. Hobson - Westwood MA, US
Neil Goldman - Norton MA, US

Assignee:

Iontera, Inc. - Dedham MA

International Classification:

A61K 9/70
A61M 35/00
A61N 1/04

Abstract:

Disclosed herein are systems, devices, and methods for transdermal delivery of a therapeutic agent (for example, a molecule or molecules) to a therapy site. The systems, devices, and methods described herein are flexible and able to conform to the contours of a therapy site, such as the shape of a user's face. In certain approaches, an activating solution is applied to the treatment or surface area of the transdermal delivery to assist with the adhering and removal of the transmittal delivery device. The activating solution can be a phase-transition solution that is activated by the temperature of the skin. Medicaments or therapeutic agents may be disposed in layers in the transdermal delivery device and/or activating solution.

US Patent:

20140364794, Dec 11, 2014

Filed:

Jun 10, 2014

Appl. No.:

14/301055

Inventors:

Michael K. Jordan - North Smithfield RI, US
Miaoyong CAO - Warwick RI, US
Christopher A. Hobson - Westwood MA, US
Matthew Gibson - Dexter MI, US

Assignee:

IONTERA, INC. - Dedham MA

International Classification:

A61N 1/30

US Classification:

604 20, 604501

Abstract:

Disclosed herein are systems, devices, and methods for transdermal delivery of a therapeutic agent (for example, a molecule or molecules) to a therapy site. The systems, devices, and methods described herein are flexible and able to conform to the contours of a therapy site, such as the shape of a user's face. In certain approaches, the devices and systems described herein include an integrated power supply for standalone application to the therapy site. The devices, systems, and methods include flexible electrodes with integrated conductance layers and interface layers for improved stability and current distribution. In practice, the device includes at least two electrodes which are coupled to the therapy site. When the electrodes are placed at the therapy site, they are electrically coupled, thereby drawing a current from the power supply to deliver the therapeutic agent to the therapy site.